VIDEO: Meeting highlights treatment advances, challenges in melanoma

Source: Healio, May 2019

NEW YORK — This year’s HemOnc Today New York meeting included a session dedicated to treatment advances and challenges in melanoma

Speakers addressed genetic testing for high-risk patients, treatment for advanced disease and controversies in adjuvant therapy.

“A lively discussion point, as usual, was the choice between combination immunotherapy or monotherapy for patients with advanced, metastatic melanoma,” program co-chair Sanjiv S. Agarwala, MD, PhD, chief of medical oncology and hematology at St. Luke’s Cancer Center and professor of medicine at Temple University, told HemOnc Today. “That’s a debate that is not going away any time soon.”